Identifying blood markers for early breast cancer detection in women with abnormal mammograms
Circulating lipid and miRNA markers for early detection of breast cancer among women with abnormal mammograms
This study is looking for ways to help women with abnormal mammogram results find out more easily whether they have breast cancer or not, by checking for certain markers in their blood, so they can avoid unnecessary and stressful follow-up procedures.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Hawaii at Manoa NIH-funded |
| Lab location | 1 site (Honolulu, United States) |
| Project ID | NIH-10673061 on NIH RePORTER |
What this research studies
This research focuses on improving the early detection of breast cancer among women who receive abnormal mammogram results. It aims to identify specific circulating lipid and miRNA markers in the blood that can help distinguish between benign conditions and early-stage breast cancer. By using these markers alongside mammography, the goal is to reduce the number of unnecessary follow-up procedures, such as biopsies, which can be costly and cause anxiety. The study builds on preliminary findings that suggest a high accuracy in differentiating between cancerous and non-cancerous conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are women who have received abnormal mammogram results and are at risk for breast cancer.
Not a fit: Patients who have already been diagnosed with breast cancer or those who have normal mammogram results are unlikely to benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate breast cancer screenings, reducing unnecessary biopsies and associated stress for patients.
How similar studies have performed: Other research has shown promising results in using blood markers for cancer detection, indicating that this approach has potential for success.
Where this research is happening
Honolulu, United States
- University of Hawaii at Manoa — Honolulu, United States (Active)
Researchers
- Principal investigator: Deng, Youping — University of Hawaii at Manoa
- Study coordinator: Deng, Youping
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.